Reposted by Jimmy Gollihar
Another update on our #CCHF vaccine that is marching towards phase I clinical trial. Here we report on the durability of protection in a mouse model of CCHFV infection. Excellent work from our colleagues at RML/NIAID🧪 www.nature.com/articles/s41...
nature.com
Replicating RNA vaccine confers durable immunity against Crimean Congo hemorrhagic fever virus challenge in mice - npj Vaccines
npj Vaccines - Replicating RNA vaccine confers durable immunity against Crimean Congo hemorrhagic fever virus challenge in mice